关于甲醇O-甲基转移酶中过渡状态的性质. 一项基于分子动力学和潜在能量表面探索的补充研究
Maite Roca1, Juan Andrés, Vicent Moliner
1Departament de Ciències Experimentals, Universitat Jaume I, 12071 Castellón, Spain.
Journal of the American Chemical Society
|July 28, 2005
概括
酶通过降低能量障碍来加速反应. 这项研究表明,甲基转移酶通过移动离子来稳定过渡状态,显著减少反应.
科学领域:
- 生物化学 生物化学
- 计算化学的计算化学
- 酶学 是一种酶学.
背景情况:
- 与未催化反应相比,酶通过降低自由能量屏障来催化生化反应.
- 了解酶催化物的精确机制仍然是一个活跃的研究领域.
研究的目的:
- 在双分子反应中研究酶催化物的静态和动态方面.
- 阐明蛋白质环境和离子在由甲基醇O-甲基转移酶催化的甲基转移反应中的作用.
主要方法:
- 量子力学/分子力学 (QM/MM) 优化被用来分析过渡向量.
- 研究了分子动力学 (MD) 轨迹,以估计传导系数并分析反应性/非反应性轨迹.
- 潜在的平均力 (PMF) 配置文件被用来定位过渡状态.
主要成果:
- 该研究确定了蛋白质环境在稳定过渡状态方面的重要作用.
- 一个关键的发现是离子与catecholate的核友和基组的近似性,由蛋白质运动驱动.
- 这种稳定性大大降低了与溶液相比,酶催化反应的自由能量屏障.
结论:
- 蛋白质和离子的动态运动对于甲基醇甲基转移酶的催化效率至关重要.
- 酶催化涉及活性部位,共因子和周围蛋白质环境之间的复杂相互作用.
- 这些发现提供了对酶性甲基转移反应背后的分子机制的见解.
更多相关视频
09:15Measuring Biomolecular DSC Profiles with Thermolabile Ligands to Rapidly Characterize Folding and Binding Interactions
Published on: November 21, 2017
07:35Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
Published on: June 1, 2022
相关概念视频
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Keto–Enol Tautomerism: Mechanism
The keto and enol forms are known as tautomers and they constantly interconvert (or tautomerize) between the two forms under acid or base catalyzed conditions. Both the reactions involve the same steps—protonation and deprotonation— although in the reverse order.
Transition State Theory
Transition-state theory, also known as activated-complex theory, provides a molecular-level explanation of reaction rates in both gas-phase and solution-phase reactions. It extends earlier kinetic models by considering the formation of a short-lived, high-energy configuration during a reaction.The progress of a chemical reaction can be represented using a reaction profile, which plots potential energy against the reaction coordinate. As two reactant molecules approach one another, their...
Protein-Drug Binding: Mechanism and Kinetics
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
